In the present study, we noted that EFTUD2 was strongly expressed in LUAD tissues by using data from online databases and confirmed these results in patient LUAD tissue samples and cell lines—consistent with its expression patterns in colorectal (24), hepatocellular (22), and endometrial (23) cancers. Here, EFTUD2 is linked to cancer.